The Library
Chemoradiotherapy for rectal cancer : an updated analysis of factors affecting pathological response
Tools
Tools
Tools
Sanghera, P., Wong, D. W. Y., McConkey, Christopher C., Geh, J. I. and Hartley, A. (2008) Chemoradiotherapy for rectal cancer : an updated analysis of factors affecting pathological response. Clinical Oncology, Vol.20 (No.2). pp. 176-183. doi:10.1016/j.clon.2007.11.013 ISSN 0936-6555.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1016/j.clon.2007.11.013
Abstract
Aims: With the aim of improving locoregional control, the use of preoperative chemoradiotherapy (CRT) for rectal cancer has increased. A pathological complete response (pCR) is often used as a surrogate marker for the efficacy of different CRT schedules. By analysing factors affecting pCR, this analysis aims to guide the development of future trials.
Materials and methods: Searches of Medline, EMBASE and the electronic American Society of Clinical Oncology abstract databases were carried out to identify prospective phase II and phase III trials using preoperative CRT to treat rectal cancer. Trials were eligible for inclusion if they defined: the CRT drugs, the radiation dose and the pCR rate. Phase I patients were excluded from the analysis. A multivariate analysis examined the effect of the above variables on the pCR rate and in addition the use of neoadjuvant chemotherapy, the type of publication (peer reviewed vs abstract), the year of publication and whether the cancers were stated to be inoperable, fixed or threatening the circumferential resection margin were included. The method of analysis used was weighted linear modelling of the pCR rate.
Results: Sixty-four phase II and seven phase III trials were identified including a total of 4732 patients. Statistically significant factors associated with pCR were the use of two drugs, the method of fluoropyrimidine administration (with continuous intravenous 5-fluorouracil being the most effective) and a higher radiotherapy dose. Although the use of two drugs was associated with a higher rate of pCR, no single schedule seemed to be more effective. None of the other factors analysed significantly influenced pCR.
Conclusions: A higher rate of pCR is seen in studies using two drugs, infusional 5-fluorouracil and a radiotherapy dose of 45 Gy and above.
| Item Type: | Journal Article | ||||
|---|---|---|---|---|---|
| Subjects: | R Medicine > RB Pathology R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology |
||||
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
| Library of Congress Subject Headings (LCSH): | Rectum -- Cancer -- Pathophysiology, Rectum -- Cancer -- Treatment -- Analysis, Chemotherapy, Radiotherapy | ||||
| Journal or Publication Title: | Clinical Oncology | ||||
| Publisher: | Elsevier Science London | ||||
| ISSN: | 0936-6555 | ||||
| Official Date: | March 2008 | ||||
| Dates: |
|
||||
| Volume: | Vol.20 | ||||
| Number: | No.2 | ||||
| Number of Pages: | 8 | ||||
| Page Range: | pp. 176-183 | ||||
| DOI: | 10.1016/j.clon.2007.11.013 | ||||
| Status: | Peer Reviewed | ||||
| Publication Status: | Published |
Data sourced from Thomson Reuters' Web of Knowledge
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
